Clinical trial
Treatment Development for Smoking Cessation and Engagement in HIV/TB
NCT05842161 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment Development for Smoking Cessation and Engagement in HIV/TB
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 12, 2024
- Completion date
- May 31, 2027
- Enrollment
- 83 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv infections, smoking cessation, tuberculosis